Diabetic Ulcer Treatment Market | 2031 Insights | Updates
The Diabetic Ulcer Treatment Market is expected to register a CAGR of 5.8% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Ulcer Type (Foot Ulcer, Mouth Ulcer, Skin Ulcer, Corneal Ulcer, Others); Treatment Type (Wound Care Dressings, Biologics, Therapy devices). The report further presents analysis based on the End User (Hospitals, Ambulatory Surgery Centers, Home Care, Community Health Centers). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Diabetic Ulcer Treatment Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Diabetic Ulcer Treatment Market Segmentation
Ulcer Type- Foot Ulcer
- Mouth Ulcer
- Skin Ulcer
- Corneal Ulcer
- Others
- Wound Care Dressings
- Biologics
- Therapy devices
- Hospitals
- Ambulatory Surgery Centers
- Home Care
- Community Health Centers
Strategic Insights
Diabetic Ulcer Treatment Market Growth Drivers- Increasing Prevalence of Diabetes and Associated Chronic Wounds:
Wounds can be classified into acute and chronic, depending on the time taken to heal. Diabetes is one of the most impactful health emergencies in the world in the 21st century. As per the American Heart Association, Inc., in 2024, ~29.3 million people in the US have been diagnosed with diabetes, and the diabetic population accounts for ~10.5% of the overall US population.
- Rise in Geriatric Population:
The elderly population is defined as a group of people aged 65 and over. Aging is one of the most significant social transformations of the 21st century. The aging population is a significantly observed issue in the Americas, Europe, and the Asia Pacific. As per the UNFPA data, globally people aged 65 or more has nearly doubled from 5.5% in 1974 to 10.3% in 2024.
- Growing Obesity:
Obesity is linked to diabetes. Excess of body fat leads to type 2 diabetes further leading to development of diabetic ulcers. As per the World Health Organization (WHO), in 2022, 1 in 8 people that is 890 people across the globe were living with obesity. This trend is expected to continue, with obesity projected to rise by 35% globally by 2030.
- Adoption of 3D Printing in Wound Care Management: Wounds caused by various due to diabetes poses a significant burden on the healthcare systems across the globe. Many research groups and companies are aiming towards 3D printing as a new treatment of diabetes wounds. For instance, researchers at the University of California, San Diego, are leading research on developing 3D-printed scaffolds using bioactive-molecule-loaded materials that support wound healing.
- Nanotechnology-based products: Research regarding nanotechnology, especially nanofibrous scaffolds (NFSs), has been rising rapidly and has led to a positive impact on diabetic wound treatment. In adjuvant treatment methods, one of the pertinent alternatives is nanofibrous scaffolds (NFSs), which have a potential greater than that of any other supplement to essential medications to accelerate the process of wound healing.
- Chitosan-based wound dressings: Chitosan is a natural, well-studied polymer, which has an extensive use in biomedical applications because of its antiseptic action and facilitation of healing. It promotes drainage and prevents the accumulation of exudates; besides, CS acts as an auto-grafting bed in wound therapy. Growing preference of chitosan-based dressing is one of the major trend witnessed in developed regions.
- Increasing Adoption of Negative Pressure Wound Therapy (NPWT) Devices: NPWT devices have been proven clinically to heal wounds as well as reduce the risk of complications in diabetes ulcers. Adopting these devices, however, remains challenging due to their cost and requirement for complexity of use. As technology remains on the move, it becomes an opportunity for companies to come up with more affordable and user-friendly NPWT devices that can push up the adoption rate and exploit the market.
- New Products for the Treatment of Wounds: Development of novel products for wound care capable of inducing faster recovery with a reduced chance of complications in diabetes ulcers are exciting avenues of application. It may include nanomaterials, bioactive molecules, and biomimetic surfaces among others. The products offer a advantage by offering improved efficacy and better patient outcomes. New products in wound care would likely find a significant market share for companies that invest in its research and development.
- High demand of Offloading devices: These offloading devices are made in such a way as to reduce the pressure and relieve the discomfort caused by a diabetes ulcer. With increasing cases of diabetes around the world, pressure offloading devices are highly demanded, especially in underdeveloped regions. Companies who invest in R&D in innovative offloading devices will reap a good amount of benefits.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Diabetic Ulcer Treatment Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Diabetic Ulcer Treatment Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The diabetes ulcer treatment market is estimated to grow with a CAGR of 5.8% from 2023 to 2031
Asia-Pacific region is likely to witness the fastest growth rate during the forecast period.
The diabetes ulcer treatment market majorly consists of players such as ConvaTec, Smith & Nephew Plc, B. Braun Melsungen AG among others.
Nanotechnology-based products is likely to remain the key trend during the forecast period.
The market drivers include the increasing prevalence of diabetes and rising geriatric population, which are driving the diabetes ulcer treatment market
North America dominated the diabetic ulcer treatment market in 2023
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Diabetic Ulcer Treatment Market - By Ulcer Type
1.3.2 Diabetic Ulcer Treatment Market - By Treatment Type
1.3.3 Diabetic Ulcer Treatment Market - By End User
1.3.4 Diabetic Ulcer Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DIABETIC ULCER TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DIABETIC ULCER TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. DIABETIC ULCER TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. DIABETIC ULCER TREATMENT - GLOBAL MARKET OVERVIEW
6.2. DIABETIC ULCER TREATMENT - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. DIABETIC ULCER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - ULCER TYPE
7.1. OVERVIEW
7.2. ULCER TYPE MARKET FORECASTS AND ANALYSIS
7.3. FOOT ULCER
7.3.1. Overview
7.3.2. Foot Ulcer Market Forecast and Analysis
7.3.3. Neuropathic Ulcers Market
7.3.3.1. Overview
7.3.3.2. Neuropathic Ulcers Market Forecast and Analysis
7.3.4. Ischemic Ulcers Market
7.3.4.1. Overview
7.3.4.2. Ischemic Ulcers Market Forecast and Analysis
7.3.5. Neuro-Ischemic Ulcers Market
7.3.5.1. Overview
7.3.5.2. Neuro-Ischemic Ulcers Market Forecast and Analysis
7.4. MOUTH ULCER
7.4.1. Overview
7.4.2. Mouth Ulcer Market Forecast and Analysis
7.5. SKIN ULCER
7.5.1. Overview
7.5.2. Skin Ulcer Market Forecast and Analysis
7.6. CORNEAL ULCER
7.6.1. Overview
7.6.2. Corneal Ulcer Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. DIABETIC ULCER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - TREATMENT TYPE
8.1. OVERVIEW
8.2. TREATMENT TYPE MARKET FORECASTS AND ANALYSIS
8.3. WOUND CARE DRESSINGS
8.3.1. Overview
8.3.2. Wound Care Dressings Market Forecast and Analysis
8.3.3. Alginate dressings Market
8.3.3.1. Overview
8.3.3.2. Alginate dressings Market Forecast and Analysis
8.3.4. Hydrofiber dressings Market
8.3.4.1. Overview
8.3.4.2. Hydrofiber dressings Market Forecast and Analysis
8.3.5. Foam dressings Market
8.3.5.1. Overview
8.3.5.2. Foam dressings Market Forecast and Analysis
8.3.6. Film dressings Market
8.3.6.1. Overview
8.3.6.2. Film dressings Market Forecast and Analysis
8.3.7. Hydrocolloid dressings Market
8.3.7.1. Overview
8.3.7.2. Hydrocolloid dressings Market Forecast and Analysis
8.3.8. Surgical dressings Market
8.3.8.1. Overview
8.3.8.2. Surgical dressings Market Forecast and Analysis
8.3.9. Hydrogel dressings Market
8.3.9.1. Overview
8.3.9.2. Hydrogel dressings Market Forecast and Analysis
8.4. BIOLOGICS
8.4.1. Overview
8.4.2. Biologics Market Forecast and Analysis
8.4.3. Growth factors Market
8.4.3.1. Overview
8.4.3.2. Growth factors Market Forecast and Analysis
8.4.4. Skin Grafts Market
8.4.4.1. Overview
8.4.4.2. Skin Grafts Market Forecast and Analysis
8.5. THERAPY DEVICES
8.5.1. Overview
8.5.2. Therapy devices Market Forecast and Analysis
8.5.3. Negative pressure wound therapy Market
8.5.3.1. Overview
8.5.3.2. Negative pressure wound therapy Market Forecast and Analysis
8.5.4. Ultrasound therapy Market
8.5.4.1. Overview
8.5.4.2. Ultrasound therapy Market Forecast and Analysis
8.5.5. Antibiotic medication Market
8.5.5.1. Overview
8.5.5.2. Antibiotic medication Market Forecast and Analysis
9. DIABETIC ULCER TREATMENT MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. AMBULATORY SURGERY CENTERS
9.4.1. Overview
9.4.2. Ambulatory Surgery Centers Market Forecast and Analysis
9.5. HOME CARE
9.5.1. Overview
9.5.2. Home Care Market Forecast and Analysis
9.6. COMMUNITY HEALTH CENTERS
9.6.1. Overview
9.6.2. Community Health Centers Market Forecast and Analysis
10. DIABETIC ULCER TREATMENT MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Diabetic Ulcer Treatment Market Overview
10.1.2 North America Diabetic Ulcer Treatment Market Forecasts and Analysis
10.1.3 North America Diabetic Ulcer Treatment Market Forecasts and Analysis - By Ulcer Type
10.1.4 North America Diabetic Ulcer Treatment Market Forecasts and Analysis - By Treatment Type
10.1.5 North America Diabetic Ulcer Treatment Market Forecasts and Analysis - By End User
10.1.6 North America Diabetic Ulcer Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Diabetic Ulcer Treatment Market
10.1.6.1.1 United States Diabetic Ulcer Treatment Market by Ulcer Type
10.1.6.1.2 United States Diabetic Ulcer Treatment Market by Treatment Type
10.1.6.1.3 United States Diabetic Ulcer Treatment Market by End User
10.1.6.2 Canada Diabetic Ulcer Treatment Market
10.1.6.2.1 Canada Diabetic Ulcer Treatment Market by Ulcer Type
10.1.6.2.2 Canada Diabetic Ulcer Treatment Market by Treatment Type
10.1.6.2.3 Canada Diabetic Ulcer Treatment Market by End User
10.1.6.3 Mexico Diabetic Ulcer Treatment Market
10.1.6.3.1 Mexico Diabetic Ulcer Treatment Market by Ulcer Type
10.1.6.3.2 Mexico Diabetic Ulcer Treatment Market by Treatment Type
10.1.6.3.3 Mexico Diabetic Ulcer Treatment Market by End User
10.2. EUROPE
10.2.1 Europe Diabetic Ulcer Treatment Market Overview
10.2.2 Europe Diabetic Ulcer Treatment Market Forecasts and Analysis
10.2.3 Europe Diabetic Ulcer Treatment Market Forecasts and Analysis - By Ulcer Type
10.2.4 Europe Diabetic Ulcer Treatment Market Forecasts and Analysis - By Treatment Type
10.2.5 Europe Diabetic Ulcer Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe Diabetic Ulcer Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Diabetic Ulcer Treatment Market
10.2.6.1.1 Germany Diabetic Ulcer Treatment Market by Ulcer Type
10.2.6.1.2 Germany Diabetic Ulcer Treatment Market by Treatment Type
10.2.6.1.3 Germany Diabetic Ulcer Treatment Market by End User
10.2.6.2 France Diabetic Ulcer Treatment Market
10.2.6.2.1 France Diabetic Ulcer Treatment Market by Ulcer Type
10.2.6.2.2 France Diabetic Ulcer Treatment Market by Treatment Type
10.2.6.2.3 France Diabetic Ulcer Treatment Market by End User
10.2.6.3 Italy Diabetic Ulcer Treatment Market
10.2.6.3.1 Italy Diabetic Ulcer Treatment Market by Ulcer Type
10.2.6.3.2 Italy Diabetic Ulcer Treatment Market by Treatment Type
10.2.6.3.3 Italy Diabetic Ulcer Treatment Market by End User
10.2.6.4 Spain Diabetic Ulcer Treatment Market
10.2.6.4.1 Spain Diabetic Ulcer Treatment Market by Ulcer Type
10.2.6.4.2 Spain Diabetic Ulcer Treatment Market by Treatment Type
10.2.6.4.3 Spain Diabetic Ulcer Treatment Market by End User
10.2.6.5 United Kingdom Diabetic Ulcer Treatment Market
10.2.6.5.1 United Kingdom Diabetic Ulcer Treatment Market by Ulcer Type
10.2.6.5.2 United Kingdom Diabetic Ulcer Treatment Market by Treatment Type
10.2.6.5.3 United Kingdom Diabetic Ulcer Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Diabetic Ulcer Treatment Market Overview
10.3.2 Asia-Pacific Diabetic Ulcer Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Diabetic Ulcer Treatment Market Forecasts and Analysis - By Ulcer Type
10.3.4 Asia-Pacific Diabetic Ulcer Treatment Market Forecasts and Analysis - By Treatment Type
10.3.5 Asia-Pacific Diabetic Ulcer Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Diabetic Ulcer Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Diabetic Ulcer Treatment Market
10.3.6.1.1 Australia Diabetic Ulcer Treatment Market by Ulcer Type
10.3.6.1.2 Australia Diabetic Ulcer Treatment Market by Treatment Type
10.3.6.1.3 Australia Diabetic Ulcer Treatment Market by End User
10.3.6.2 China Diabetic Ulcer Treatment Market
10.3.6.2.1 China Diabetic Ulcer Treatment Market by Ulcer Type
10.3.6.2.2 China Diabetic Ulcer Treatment Market by Treatment Type
10.3.6.2.3 China Diabetic Ulcer Treatment Market by End User
10.3.6.3 India Diabetic Ulcer Treatment Market
10.3.6.3.1 India Diabetic Ulcer Treatment Market by Ulcer Type
10.3.6.3.2 India Diabetic Ulcer Treatment Market by Treatment Type
10.3.6.3.3 India Diabetic Ulcer Treatment Market by End User
10.3.6.4 Japan Diabetic Ulcer Treatment Market
10.3.6.4.1 Japan Diabetic Ulcer Treatment Market by Ulcer Type
10.3.6.4.2 Japan Diabetic Ulcer Treatment Market by Treatment Type
10.3.6.4.3 Japan Diabetic Ulcer Treatment Market by End User
10.3.6.5 South Korea Diabetic Ulcer Treatment Market
10.3.6.5.1 South Korea Diabetic Ulcer Treatment Market by Ulcer Type
10.3.6.5.2 South Korea Diabetic Ulcer Treatment Market by Treatment Type
10.3.6.5.3 South Korea Diabetic Ulcer Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Diabetic Ulcer Treatment Market Overview
10.4.2 Middle East and Africa Diabetic Ulcer Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Diabetic Ulcer Treatment Market Forecasts and Analysis - By Ulcer Type
10.4.4 Middle East and Africa Diabetic Ulcer Treatment Market Forecasts and Analysis - By Treatment Type
10.4.5 Middle East and Africa Diabetic Ulcer Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Diabetic Ulcer Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Diabetic Ulcer Treatment Market
10.4.6.1.1 South Africa Diabetic Ulcer Treatment Market by Ulcer Type
10.4.6.1.2 South Africa Diabetic Ulcer Treatment Market by Treatment Type
10.4.6.1.3 South Africa Diabetic Ulcer Treatment Market by End User
10.4.6.2 Saudi Arabia Diabetic Ulcer Treatment Market
10.4.6.2.1 Saudi Arabia Diabetic Ulcer Treatment Market by Ulcer Type
10.4.6.2.2 Saudi Arabia Diabetic Ulcer Treatment Market by Treatment Type
10.4.6.2.3 Saudi Arabia Diabetic Ulcer Treatment Market by End User
10.4.6.3 U.A.E Diabetic Ulcer Treatment Market
10.4.6.3.1 U.A.E Diabetic Ulcer Treatment Market by Ulcer Type
10.4.6.3.2 U.A.E Diabetic Ulcer Treatment Market by Treatment Type
10.4.6.3.3 U.A.E Diabetic Ulcer Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Diabetic Ulcer Treatment Market Overview
10.5.2 South and Central America Diabetic Ulcer Treatment Market Forecasts and Analysis
10.5.3 South and Central America Diabetic Ulcer Treatment Market Forecasts and Analysis - By Ulcer Type
10.5.4 South and Central America Diabetic Ulcer Treatment Market Forecasts and Analysis - By Treatment Type
10.5.5 South and Central America Diabetic Ulcer Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America Diabetic Ulcer Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Diabetic Ulcer Treatment Market
10.5.6.1.1 Brazil Diabetic Ulcer Treatment Market by Ulcer Type
10.5.6.1.2 Brazil Diabetic Ulcer Treatment Market by Treatment Type
10.5.6.1.3 Brazil Diabetic Ulcer Treatment Market by End User
10.5.6.2 Argentina Diabetic Ulcer Treatment Market
10.5.6.2.1 Argentina Diabetic Ulcer Treatment Market by Ulcer Type
10.5.6.2.2 Argentina Diabetic Ulcer Treatment Market by Treatment Type
10.5.6.2.3 Argentina Diabetic Ulcer Treatment Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DIABETIC ULCER TREATMENT MARKET, KEY COMPANY PROFILES
12.1. CONVATEC, INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ACELITY L.P. INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. 3M
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. COLOPLAST A/S
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SMITH AND NEPHEW PLC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. B. BRAUN MELSUNGEN AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. MEDLINE INDUSTRIES, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MEDTRONIC PLC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CARDINAL HEALTH.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. MOLNLYCKE HEALTH CARE AB
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. ConvaTec, Inc.2. Acelity L.P. Inc.3. 3M4. Coloplast A/S5. Smith & Nephew Plc.6. B. Braun Melsungen AG7. Medline Industries, Inc.8. Medtronic Plc.9. Cardinal Health10. Molnlycke Health Care AB
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For